A Comparative Study of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration: 12-Month Outcomes of Polish Therapeutic Program in Non-Tertiary Institution

Introduction This single-center study aimed to compare the 12-month treatment outcomes of ranibizumab with that of aflibercept in routine clinical practice. Methods Cohort of patients diagnosed with treatment-naïve neovascular age-related macular degeneration (AMD), treated using either ranibizumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Skrzypczak, Tomasz, Jany, Aleksandra, Bugajska-Abramek, Ewa, Bogusławska, Joanna, Kowal-Lange, Agnieszka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Ophthalmology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312781/
https://www.ncbi.nlm.nih.gov/pubmed/34336421
http://dx.doi.org/10.7759/cureus.15916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312781/
https://www.ncbi.nlm.nih.gov/pubmed/34336421
http://dx.doi.org/10.7759/cureus.15916

Ejemplares similares